
OMCL · NASDAQ
Omnicell, Inc.
$36.88 -0.88 (-2.39%)
Company overview
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies in the United States and internationally. The company offers point-of-care automation solutions to improve clinician workflows in patient care areas; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating rooms; Omnicell Interface Software that provides integration between its medication-use or supply products and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Exchange
- NASDAQ
- Market cap
- $1.7B
- Employees
- 3,620
- Headquarters
- Mountain View, CA
- Website
- omnicell.com
- CEO
- Randall A. Lipps
- Listed
- August 9, 2001
- P/E
- 82.90
- Dividend yield
- 0.00%
Company financials
- Revenue
- $1.2B
- Gross profit
- $533M
- Operating income
- $34.6M
- EBITDA
- $118M
- Net income
- $20.4M
- EPS
- $0.44
- Total assets
- $2B
- Total debt
- $202M
- Gross margin
- 43.50%
- Net margin
- 1.67%
- Earnings yield
- 1.21%
Showing FY 2025